Europe Clinical Trials Market Forecast to 2028 - Regional Analysis

List of Tables

The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a CAGR of 5.5% from 2022 to 2028.

Increasing Adoption and Outsourcing of Clinical Trials Fuels Europe clinical trials market.

Clinical trials help determine if a new form of treatment or prevention, such as a new drug, diet, or medical device, is safe and effective. The trials are mainly carried out during drug development. According to European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are authorized annually, of which about 60% of clinical trials are associated with the pharmaceutical industry. An increasing number of clinical trials for developing different effective treatments due to the rising prevalence of chronic diseases is fueling the growth of the clinical trials market.

Further, clinical trials are increasingly becoming complex procedures, owing to which proper execution and overseeing of the operation occurring in research-based organizations has become crucial. To avoid errors due to improper execution, research-based organizations are outsourcing clinical trials to develop their products. Clinical research organizations (CROs) assist in successfully implementing clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations benefitting trial sponsors. Thus, the development of cost-effective solutions and decreasing errors in CROs during the drug development process are driving the clinical trials market growth.

Europe Clinical Trials Market Overview

The Europe clinical trials market has been segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising number of clinical trial activities for new drug development and innovative product launches by the companies will likely enhance the market growth in Europe during the forecast period.

Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure, Moreover, there is a large patient pool and a high demand for quality healthcare in the country. Coordinating centers for clinical trials were established as part of a new funding program under the Federal Ministry of Education and Research to foster academic clinical research. Clinical trials in Germany are approved by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute, depending on the product to be investigated. Therefore, Germany's clinical trial approval processes are standardized, reliable, transparent, and approved for relatively short study start-up timelines. Further, top CROs in Germany provide several clinical trial services. Sofpromed manages clinical trials in Germany and other EU member states. It offers a full range of CRO services for pharmaceutical and biotechnology companies. Similarly, CONET GmbH, headquartered in Mannheim, Germany, offers clinical trial management services from small pilot studies to large multicenter international clinical trials for all phases (1-4), including pediatric clinical trials and medical device trials as per EU Directives.

Europe clinical trials market Revenue and Forecast to 2028 (US$ Million)

Europe Clinical Trials Market Segmentation

The Europe clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the Europe clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest Europe clinical trials market share in 2022.

Based on study design, the Europe clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest Europe clinical trials market share in 2022.

Based on indication, the Europe clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest Europe clinical trials market share in 2022.

Based on country, the Europe clinical trials market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe clinical trials market in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the Europe clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00028989

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Clinical Trials Market - By Phase
- 1.3.2 Europe Clinical Trials Market - By Study Design
- 1.3.3 Europe Clinical Trials Market - By Indication
- 1.3.4 Europe Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - Europe Analysis

6.1 Europe Clinical Trials Market Revenue Forecast and Analysis

7. Europe Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Clinical Trials Market - By Phase

8.1 Overview
8.2 Europe Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Europe: Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Germany: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 Germany: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 Germany: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 UK: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 UK: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 UK: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 France: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 France: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 France: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.4 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Italy: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.4.4 Italy: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.4.5 Italy: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.5 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.3 Spain: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.5.4 Spain: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.5.5 Spain: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.6 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 IXICO Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ICON Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SGS SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Syneos Health Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms